Regulation

© patpitchaya / Getty Images

ILSI brings together industry giants in vitamin K2 task force

By Nikki Hancocks

International Life Sciences Institute (ILSI) Europe has announced a new Vitamin K2 task force, designated to advance the scientific understanding of the health benefits of Vitamin K2 and provide evidence-based insights to enhance public awareness.

NutraCast: Exploring the connection of ‘science to sales’

NutraCast: Exploring the connection of ‘science to sales’

By Danielle Masterson

The dietary supplement industry has come a long way. A significant number of new dietary supplement products have appeared in the marketplace since Congress passed the Dietary Supplement and Health Education Act (DSHEA) of 1994. At that time, there were...

FTC settles with supplement startup over COVID claims

FTC settles with supplement startup over COVID claims

By Asia Sherman

A multi-year case involving dietary supplement startup PPO Lab, the Federal Trade Commission (FTC) and COVID-19-related health claims has come to a close, culminating in a truce that removes fines and lightens administrative burdens on the defendants.

NutraCast: Safety considerations for dietary supplement manufacturers

NutraCast: Safety considerations for dietary supplement manufacturers

By Danielle Masterson

A new paper is out titled “Safety Considerations for Dietary Supplement Manufacturers in the United States", co-authored by Jay Sirois, PhD, VP of regulatory and scientific affairs, Consumer Healthcare Products Association, alongside several CHPA...

Getty Images / Shavon

What can you say in weight loss claims? Experts weigh in

By Danielle Masterson

With what feels like a weight loss medication takeover, many are betting that the GLP-1 receptor agonists will rescue America from its obesity epidemic. So what does this mean for the natural weight loss products?

Getty Images | oonal

Industry demands closure to CBD regulation stalemate

By Nikki Hancocks

The Association for the Cannabinoid Industry (ACI) has published a report calling on the UK Food Standards Agency (FSA) and the Home Office to work together to end the regulatory stalemate threatening the sector.

Where Advocacy Meets Diplomacy: 2023 Demanded a Full Toolbox

CRN's Steve Mister on 2023

Where Advocacy Meets Diplomacy: 2023 Demanded a Full Toolbox

By Steve Mister, President & CEO, Council for Responsible Nutrition

As my grandmother used to say, “You get more flies with sugar than you do with vinegar—but a good bug zapper will do the job sometimes too.“ Yes, she was a wise and pragmatic woman.

© Parradee Kietsirikul / Getty Images

UNPA's reflections on 2023: The year of opposite choices

By Loren Israelsen, Founder & President, United Natural Products Alliance (UNPA)

My reflection on 2023 has little to do with specifics. In my view, this was a year of opposite choices and opposing directions – the big stuff. Yet, daily demands to address the urgent (but often not so important) dulled our senses and intuition. Hence,...

© Anastasiia Stiahailo / Getty Images

Guest article

The Future of Self-Care Depends on Continued Access & Expanded Choice

By Duffy MacKay, SVP, Dietary Supplements, CHPA

The future of self-care is a multifaceted landscape that hinges on access, continued innovation, and a collective effort spanning input from consumers, communities, healthcare providers, regulators, and policymakers.

NutraCast: Are energy drinks under attack? FoodChain ID weighs in

NutraCast: Are energy drinks under attack? FoodChain ID weighs in

By Danielle Masterson

As caffeine content in energy drinks climbs to new heights, some countries and retailers are banning the products or imposing age restrictions. In the US and UK, there are no national regulations that ban the sale of highly-caffeinated energy drinks,...

FDA & Pharmavite join speaker roster for the DSHEA Summit

FDA & Pharmavite join speaker roster for the DSHEA Summit

By Stephen Daniells

Dr Cara Welch, Director of FDA’s Office of Dietary Supplements Programs, and Christine Burdick-Bell, EVP & General Counsel at Pharmavite, have confirmed their participation in the NutraIngredients-USA’s landmark DSHEA Summit.

© Edalin / Getty Images

FDA delays response to Nammex’s Mushroom product labeling petition

By Stephen Daniells

The US Food and Drug Administration has declined to respond to a Citizen Petition by North American Reishi Ltd (“Nammex”) on the labeling and sale of food and supplements containing fungal ingredients, citing “competing agency priorities”.

Follow us

Products

View more

Webinars